Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1056, 2005-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Celecoxib 200 mg/day has a beneficial anti-inflammatory effect in patients with AS
Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. :
Sanofi-aventis has launched its rimonabant 20 mg/day [Acomplia] in the UK
Inpharma, Vol. 1, Iss. 1545, 2006-01 ,pp. :
The antimalarial combination of artemisinin plus naphthoquine [Arco] has been launched in Nigeria
Inpharma, Vol. 1, Iss. 1548, 2006-01 ,pp. :